![](https://endpts.com/wp-content/uploads/2022/08/Keting-Chu-Bluejay-tile.jpg)
Keting Chu, Bluejay Therapeutics CEO
Novartis-partnered biotech nabs new cash, boosting efforts to develop 'functional cure' for chronic hepatitis B
Every year, 820,000 people die of chronic hepatitis B infections globally, and 1.5 million get infected, despite the availability of vaccines and treatments, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.